CYP450 2C9 drug metabolizing enzyme and VKORC1 genotyping system
ODV,ODW
Vitamin k epoxide reductase complex subunit one (vkorc1) genotyping system,Cytoc
Vitamin k epoxide reductase complex subunit one (vkorc1) genotyping system,Cytochrome P450 2C9 (Cyp450 2c9) drug metabolizing enzyme genotyping system
CYP2C19 drug metabolyzing enzyme genotyping system
NSU,NTI
Instrumentation for clinical multiplex test systems,Drug metabolizing enzyme gen
Instrumentation for clinical multiplex test systems,Drug metabolizing enzyme genotyping systems
Genotyping system for the detection of Factor II (Prothrombin) G20210A and Facto
Genotyping system for the detection of Factor II (Prothrombin) G20210A and Factor V Leiden G1691A mutations
NPQ,NSU,NPR
TEST, FACTOR V LEIDEN MUTATIONS, GENOMIC DNA PCR,Instrumentation for clinical mu
TEST, FACTOR V LEIDEN MUTATIONS, GENOMIC DNA PCR,Instrumentation for clinical multiplex test systems,TEST, FACTOR II G20210A MUTATIONS, GENOMIC DNA PCR
CYP2C19 drug metabolyzing enzyme genotyping system
NTI,NSU
Drug metabolizing enzyme genotyping systems,Instrumentation for clinical multipl
Drug metabolizing enzyme genotyping systems,Instrumentation for clinical multiplex test systems
Genotyping system for the detection of Factor II (Prothrombin) G20210A mutation
NPR,NSU
TEST, FACTOR II G20210A MUTATIONS, GENOMIC DNA PCR,Instrumentation for clinical
TEST, FACTOR II G20210A MUTATIONS, GENOMIC DNA PCR,Instrumentation for clinical multiplex test systems
Genotyping system for the detection of Factor II (Prothrombin) G20210A and Facto
Genotyping system for the detection of Factor II (Prothrombin) G20210A and Factor V Leiden G1691A mutations
NSU,NPQ,NPR
Instrumentation for clinical multiplex test systems,TEST, FACTOR V LEIDEN MUTATI
Instrumentation for clinical multiplex test systems,TEST, FACTOR V LEIDEN MUTATIONS, GENOMIC DNA PCR,TEST, FACTOR II G20210A MUTATIONS, GENOMIC DNA PCR
Genotyping system for the detection of Factor II (Prothrombin) G20210A mutations.
NPR,NSU
TEST, FACTOR II G20210A MUTATIONS, GENOMIC DNA PCR,Instrumentation for clinical
TEST, FACTOR II G20210A MUTATIONS, GENOMIC DNA PCR,Instrumentation for clinical multiplex test systems
Genotyping systme for the detection of the Factor V Leiden G1691A mutation
NSU,NPQ
Instrumentation for clinical multiplex test systems,TEST, FACTOR V LEIDEN MUTATI
Instrumentation for clinical multiplex test systems,TEST, FACTOR V LEIDEN MUTATIONS, GENOMIC DNA PCR
Genotyping system for the detection of the Factor V Leiden G1691A mutation
NPQ,NSU
TEST, FACTOR V LEIDEN MUTATIONS, GENOMIC DNA PCR,Instrumentation for clinical mu
TEST, FACTOR V LEIDEN MUTATIONS, GENOMIC DNA PCR,Instrumentation for clinical multiplex test systems
2
INFINITI® Factor V Leiden BioFilmChip® Microarray Magazine
Genotyping system for the detection of Factor II (Prothrombin) G20210A mutations.
NPR,NSU
TEST, FACTOR II G20210A MUTATIONS, GENOMIC DNA PCR,Instrumentation for clinical
TEST, FACTOR II G20210A MUTATIONS, GENOMIC DNA PCR,Instrumentation for clinical multiplex test systems
2
INFINITI® Factor II BioFilmChip® Microarray Magazine
CYP2C19 drug metabolyzing enzyme genotyping system
NTI,NSU
Drug metabolizing enzyme genotyping systems,Instrumentation for clinical multipl
Drug metabolizing enzyme genotyping systems,Instrumentation for clinical multiplex test systems
Genotyping system for the detection of the Factor V Leiden G1691A mutation
NPQ,NSU
TEST, FACTOR V LEIDEN MUTATIONS, GENOMIC DNA PCR,Instrumentation for clinical mu
TEST, FACTOR V LEIDEN MUTATIONS, GENOMIC DNA PCR,Instrumentation for clinical multiplex test systems
2
INFINITI® Factor V Leiden Intellipac® Reagent Module
1. Aptiva Celiac Disease IgA Reagent Cartridge contains reagents to process 250
1. Aptiva Celiac Disease IgA Reagent Cartridge contains reagents to process 250 samples.a. tTG, DGP, and Control paramagnetic particles, preserved. b. Assay Buffer – colored pink, containing protein stabilizers and preservatives.c. PE Tracer IgA – PE labeled anti-human IgA antibody, containing buffer, protein stabilizers and preservative.d. Rehydration Buffer - containing protein stabilizers and preservatives
The Prep Station is a part of the nCounter DX Analysis System, which consists of
The Prep Station is a part of the nCounter DX Analysis System, which consists of two instruments, the nCounter Prep Station 5s and the nCounter Digital Analyzer 5s. The Prep Station is the automated fluidic handling component of the nCounter DX Analysis System which processes samples post-hybridization. The samples prepared by the Prep Station are used for data collection on the nCounter Digital Analyzer. Together,the NanoString nCounter DX Analysis System (liquid handling robot and epifluorescence scanner) delivers direct, multiplexed measurements of gene expression through digital readouts of the relative abundance of mRNA transcripts using the following steps: 1) a hybridization of the mRNA to fluorescent Reporter Probes and Capture Probes, 2) purification of the target/probe complexes using nCounter Prep Plates containing reagents necessary for post-hybridization processing and immobilization onto the nCounter Cartridge on the nCounter Prep Station, and 3) analysis of the nCounter Cartridge on the nCounter Digital Analyzer to provide a test result.
The Digital analyzer is a part of the nCounter DX Analysis System, which consist
The Digital analyzer is a part of the nCounter DX Analysis System, which consists of two instruments, the nCounter Prep Station 5s and the nCounter Digital Analyzer 5s. The Digital Analyzer is a multi-channel epifluorescence scanner configured specifically for use with NanoString’s nCounter Test Kit Cartridges.The nCounter Digital Analyzer collects data by taking images of the immobilized fluorescent reporters in the sample cartridge with a CCD camera through a microscope objective lens. Together,the NanoString nCounter DX Analysis System (liquid handling robot and epifluorescence scanner) delivers direct, multiplexed measurements of gene expression through digital readouts of the relative abundance of mRNA transcripts using the following steps: 1) a hybridization of the mRNA to fluorescent Reporter Probes and Capture Probes, 2) purification of the target/probe complexes using nCounter Prep Plates containing reagents necessary for post-hybridization processing and immobilization onto the nCounter Cartridge on the nCounter Prep Station, and 3) analysis of the nCounter Cartridge on the nCounter Digital Analyzer to provide a test result.
The Verigene® Processor SP is an instrument which integrates sample preparation,
The Verigene® Processor SP is an instrument which integrates sample preparation, target amplification, and target hybridization within a single device as part of the Verigene® System, a benchtop molecular diagnostics workstation that utilizes patented gold nanoparticle technology to detect nucleic acid targets of interest for a variety of applications. (Refurbished)
The Verigene® Reader is the central control of the Verigene® System, a benchtop
The Verigene® Reader is the central control of the Verigene® System, a benchtop molecular diagnostics workstation that utilizes patented gold nanoparticle technology to detect nucleic acid targets of interest for a variety of applications. (Refurbished)
The Verigene® Processor is an instrument which internalizes all of the functions
The Verigene® Processor is an instrument which internalizes all of the functions required to process a Test Cartridge as part of the Verigene® System, a benchtop molecular diagnostics workstation that utilizes patented gold nanoparticle technology to detect nucleic acid targets of interest for a variety of applications.
The Verigene® Hypercoagulation Panel Nucleic Acid Test contains the Verigene®
The Verigene® Hypercoagulation Panel Nucleic Acid Test contains the Verigene® F5 Nucleic Acid Test, the Verigene® F2 Nucleic Acid Test and the Verigene® MTHFR Nucleic Acid Test. The Verigene® F5 Nucleic Acid Test is an in vitro diagnostic for the detection and genotyping of a single point mutation (G to A at position 1691; also known as Factor V Leiden) of the human Factor V gene (F5; Coagulation Factor V gene) in patients with suspected thrombophilia, from isolated genomic DNA obtained from whole blood samples. The Verigene® F2 Nucleic Acid Test is an in vitro diagnostic for the detection and genotyping of a single point mutation (G to A at position 20210) of the human Factor II gene (F2; prothrombin gene) in patients with suspected thrombophilia, from isolated genomic DNA obtained from whole blood samples. The Verigene® MTHFR Nucleic Acid Test is an in vitro diagnostic for the detection and genotyping of a single point mutation (C to T at position 677) of the human 5,10 methylenetetrahydrofolate reductase gene (MTHFR) in patients with suspected thrombophilia, from isolated genomic DNA obtained from whole blood samples.
The Verigene® Hypercoagulation Panel Nucleic Acid Test contains the Verigene®
The Verigene® Hypercoagulation Panel Nucleic Acid Test contains the Verigene® F5 Nucleic Acid Test, the Verigene® F2 Nucleic Acid Test and the Verigene® MTHFR Nucleic Acid Test. The Verigene® F5 Nucleic Acid Test is an in vitro diagnostic for the detection and genotyping of a single point mutation (G to A at position 1691; also known as Factor V Leiden) of the human Factor V gene (F5; Coagulation Factor V gene) in patients with suspected thrombophilia, from isolated genomic DNA obtained from whole blood samples. The Verigene® F2 Nucleic Acid Test is an in vitro diagnostic for the detection and genotyping of a single point mutation (G to A at position 20210) of the human Factor II gene (F2; prothrombin gene) in patients with suspected thrombophilia, from isolated genomic DNA obtained from whole blood samples. The Verigene® MTHFR Nucleic Acid Test is an in vitro diagnostic for the detection and genotyping of a single point mutation (C to T at position 677) of the human 5,10 methylenetetrahydrofolate reductase gene (MTHFR) in patients with suspected thrombophilia, from isolated genomic DNA obtained from whole blood samples.
The Verigene® Hypercoagulation Panel Nucleic Acid Test contains the Verigene®
The Verigene® Hypercoagulation Panel Nucleic Acid Test contains the Verigene® F5 Nucleic Acid Test, the Verigene® F2 Nucleic Acid Test and the Verigene® MTHFR Nucleic Acid Test. The Verigene® F5 Nucleic Acid Test is an in vitro diagnostic for the detection and genotyping of a single point mutation (G to A at position 1691; also known as Factor V Leiden) of the human Factor V gene (F5; Coagulation Factor V gene) in patients with suspected thrombophilia, from isolated genomic DNA obtained from whole blood samples. The Verigene® F2 Nucleic Acid Test is an in vitro diagnostic for the detection and genotyping of a single point mutation (G to A at position 20210) of the human Factor II gene (F2; prothrombin gene) in patients with suspected thrombophilia, from isolated genomic DNA obtained from whole blood samples. The Verigene® MTHFR Nucleic Acid Test is an in vitro diagnostic for the detection and genotyping of a single point mutation (C to T at position 677) of the human 5,10 methylenetetrahydrofolate reductase gene (MTHFR) in patients with suspected thrombophilia, from isolated genomic DNA obtained from whole blood samples.
Hypercoagulation Panel (HC) Nucleic Acid Test Cartridge
The Verigene® Hypercoagulation Panel Nucleic Acid Test contains the Verigene®
The Verigene® Hypercoagulation Panel Nucleic Acid Test contains the Verigene® F5 Nucleic Acid Test, the Verigene® F2 Nucleic Acid Test and the Verigene® MTHFR Nucleic Acid Test. The Verigene® F5 Nucleic Acid Test is an in vitro diagnostic for the detection and genotyping of a single point mutation (G to A at position 1691; also known as Factor V Leiden) of the human Factor V gene (F5; Coagulation Factor V gene) in patients with suspected thrombophilia, from isolated genomic DNA obtained from whole blood samples. The Verigene® F2 Nucleic Acid Test is an in vitro diagnostic for the detection and genotyping of a single point mutation (G to A at position 20210) of the human Factor II gene (F2; prothrombin gene) in patients with suspected thrombophilia, from isolated genomic DNA obtained from whole blood samples. The Verigene® MTHFR Nucleic Acid Test is an in vitro diagnostic for the detection and genotyping of a single point mutation (C to T at position 677) of the human 5,10 methylenetetrahydrofolate reductase gene (MTHFR) in patients with suspected thrombophilia, from isolated genomic DNA obtained from whole blood samples.
Hypercoagulation Panel (HC) Nucleic Acid Test Cartridge
The Verigene® Processor SP is an instrument which integrates sample preparation,
The Verigene® Processor SP is an instrument which integrates sample preparation, target amplification, and target hybridization within a single device as part of the Verigene® System, a benchtop molecular diagnostics workstation that utilizes patented gold nanoparticle technology to detect nucleic acid targets of interest for a variety of applications.
The Verigene® Reader is the central control of the Verigene® System, a benchtop
The Verigene® Reader is the central control of the Verigene® System, a benchtop molecular diagnostics workstation that utilizes patented gold nanoparticle technology to detect nucleic acid targets of interest for a variety of applications.
In-vitro multiplex assay used with the Biocode MDx 3000 for the detection of res
In-vitro multiplex assay used with the Biocode MDx 3000 for the detection of respiratory pathogens.
Genotyping system for the detection of Factor II (Prothrombin) G20210A and Facto
Genotyping system for the detection of Factor II (Prothrombin) G20210A and Factor V Leiden G1691A mutations
Genotyping system for the detection of Factor II (Prothrombin) G20210A and Facto
Genotyping system for the detection of Factor II (Prothrombin) G20210A and Factor V Leiden G1691A mutations
Genotyping system for the detection of Factor II (Prothrombin) G20210A and Facto
Genotyping system for the detection of Factor II (Prothrombin) G20210A and Factor V Leiden G1691A mutations